StockData
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31

MEDIFAST INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$12.03+0.15 (+1.26%)

Close on Oct 19, 2026

Market cap
$133.95M
P/E (TTM)
–
Dividend yield
0.00%

MEDIFAST INC balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
69.2%
Operating margin
-6.2%
Net margin
-8.1%
Return on equity, FY2025
-9.1%

Financial strength

Current ratio
4.86
Debt to equity
–
Debt to assets
–
Cash to current liabilities
173.0%

Valuation

P/E ratio
–
Price to sales
0.42
Price to book
0.68
Dividend yield
0.00%